Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.

Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Wang J.

PLoS One. 2013;8(3):e59918. doi: 10.1371/journal.pone.0059918.

2.

Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.

Simms NA, Rajput A, Sharratt EA, Ongchin M, Teggart CA, Wang J, Brattain MG.

BMC Cancer. 2012 Jun 6;12:221. doi: 10.1186/1471-2407-12-221.

3.

Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.

Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG.

Cancer Res. 2008 May 1;68(9):3152-60. doi: 10.1158/0008-5472.CAN-07-5348.

4.

MicroRNA-192 suppresses liver metastasis of colon cancer.

Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Are C, Brattain M, Wang J.

Oncogene. 2014 Nov 13;33(46):5332-40. doi: 10.1038/onc.2013.478.

5.

Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.

Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Watanabe A, Aburatani H, Miyoshi H, Kiyono K, Shirai YT, Suzuki HI, Hirakawa K, Kano MR, Miyazono K.

J Natl Cancer Inst. 2009 Apr 15;101(8):592-604. doi: 10.1093/jnci/djp058.

6.

c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.

Kiyono K, Suzuki HI, Morishita Y, Komuro A, Iwata C, Yashiro M, Hirakawa K, Kano MR, Miyazono K.

Cancer Sci. 2009 Oct;100(10):1809-16. doi: 10.1111/j.1349-7006.2009.01248.x.

7.

Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.

Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, Ten Dijke P.

Oncogene. 2010 Mar 4;29(9):1351-61. doi: 10.1038/onc.2009.426.

PMID:
20010874
8.

PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A.

Zhou YH, Hu Y, Mayes D, Siegel E, Kim JG, Mathews MS, Hsu N, Eskander D, Yu O, Tromberg BJ, Linskey ME.

J Neurooncol. 2010 Jan;96(2):191-200. doi: 10.1007/s11060-009-9963-8.

9.

Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.

Jie JZ, Wang JW, Qu JG, Hung T.

World J Gastroenterol. 2007 Apr 7;13(13):1938-46.

10.

Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.

Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.

Clin Cancer Res. 2008 Aug 1;14(15):4961-70. doi: 10.1158/1078-0432.CCR-07-4604.

11.

The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer.

Are C, Simms N, Rajput A, Brattain M.

HPB (Oxford). 2010 Sep;12(7):498-506. doi: 10.1111/j.1477-2574.2010.00219.x. Erratum in: HPB (Oxford). 2011 Aug;13(8):593. Rajupt, Ashwani [corrected to Rajput, Ashwani].

12.

Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer.

Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD, Radinsky R, Gallick GE, Ellis LM.

Lab Invest. 2002 Oct;82(10):1377-89.

PMID:
12379772
13.
14.
15.

Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.

Anumanthan G, Halder SK, Osada H, Takahashi T, Massion PP, Carbone DP, Datta PK.

Br J Cancer. 2005 Nov 14;93(10):1157-67.

16.
17.
18.

Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.

Hsu S, Huang F, Friedman E.

J Cell Physiol. 1995 Nov;165(2):239-45.

PMID:
7593201
19.

Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.

Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.

Cancer Res. 1999 Sep 15;59(18):4725-31.

20.

A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.

Guan H, Zhou Z, Wang H, Jia SF, Liu W, Kleinerman ES.

Clin Cancer Res. 2005 Apr 1;11(7):2662-9.

Items per page

Supplemental Content

Support Center